E. Thomas Corcoran - 24 Feb 2025 Form 4 Insider Report for PHIBRO ANIMAL HEALTH CORP (PAHC)

Reporting relationship: Director
Issuer ticker: PAHC
Reported as of: 24 Feb 2025
Net transaction value: +$110,500
SEC form: 4
Accepted by SEC: 26 Feb 2025, 16:15:17 UTC
Prior SEC filing: 06 Sep 2024
Next SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Judith Weinstein, as Attorney-in-Fact for E. Thomas Corcoran

Key filing fact

E. Thomas Corcoran filed Form 4 for PHIBRO ANIMAL HEALTH CORP (PAHC) on 26 Feb 2025.

Key facts

This page summarizes E. Thomas Corcoran's Form 4 filing for PHIBRO ANIMAL HEALTH CORP (PAHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Feb 2025, 16:15.

Change

Previous filing in this sequence was filed on 06 Sep 2024.
Current net transaction value: +$110,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PAHC transaction

Class A Common Stock

Purchase

Transaction value: $110,500
Shares: +5,000
Change %: +20%
Price: $22.10
Shares after: 30,000
Date: 24 Feb 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.02 to $22.11. The Reporting Person undertakes to provide to the Issuer, any security holders of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within this range.